Beneficient (BENF) is a technology-enabled financial services company headquartered in Dallas, Texas. StockAnalysis+2b2idigital.com+2 The firm serves a niche but growing segment: investors in alternative assets — such as private equity, venture capital, real estate, funds, co-investments, and other illiquid vehicles — and offers solutions to provide liquidity or exit options for those assets. Beneficient+1

Replimune Group, Inc. (NASDAQ : REPL) is a clinical-stage biotechnology company headquartered in Woburn, Massachusetts, focused on a novel class of therapies known as oncolytic immunotherapies, developed via its proprietary RPx platform. Replimune+2Replimune+2

Rani Therapeutics is a clinical-stage biopharma company focused on enabling the oral delivery of biologics and drugs. Its signature technology is the RaniPill® capsule (also called RaniPill / robotic pill / RaniPill HC), with the goal of replacing subcutaneous injections or infusions with swallowable capsules. Rani Therapeutics, LLC+3Rani Therapeutics, LLC+3ranitherapeutics.com+3

In the fast-moving world of consumer technology, ideas are plentiful, but defensibility is rare. Anyone can replicate a product’s features, but few companies can build intellectual property (IP) moats that ensure long-term competitive advantage. That’s why some of the world’s most valuable acquisitions have revolved around proprietary technology, not just user growth.

Chesapeake, Va. — [Date] — Greenwave Technology Solutions, Inc. (NASDAQ: GWAV), a company operating in the metal recycling sector, confirmed today that it has implemented a 1-for-110 reverse stock split of its common shares, effective August 22, 2025. The move is intended to boost the per-share price and bring the company back into compliance with Nasdaq’s minimum bid price rule. Quiver Quantitative+1

Welcome in today’s deep dive into ESS Tech, Inc. (NYSE: GWH) — a small-cap clean energy play centered on long-duration energy storage (LDES) using iron flow battery technology. For SCN’s retail investor base, we’ll cover what the company does, where it’s heading, the opportunities and risks, and how GWH might fit into a speculative or thematic portfolio.

U.S. equity markets took a modest step back on Thursday, coming off recent highs and digesting mixed signals across macro, policy, and valuation domains. The S&P 500, Nasdaq, and Dow all slipped about 0.2% to 0.4% intraday, with volatility creeping into names that dominated earlier runs. euronews+3AP News+3Investors+3

Xenetic Biosciences, Inc. (ticker: XBIO) is a small-cap biotech / immuno-oncology company pushing into a specialized niche of cancer therapy. Xenetic Biosciences, Inc.+2StockAnalysis+2 The core of its strategy is the development of a DNase-based oncology platform — specifically, the use of recombinant DNase I to target neutrophil extracellular traps (NETs) in the tumor microenvironment. Xenetic Biosciences, Inc.+3Xenetic Biosciences, Inc.+3Xenetic Biosciences, Inc.+3

When most investors think about smartphones, their minds go straight to mainstream consumer devices like Apple’s iPhone or Samsung’s Galaxy line. But there’s another side of the market that doesn’t get as much attention: rugged smartphones.

Lithium Americas Corp. (TSX: LAC | NYSE: LAC) made waves on October 1 after confirmation that the U.S. government will acquire a 5% equity stake in the company and in its flagship Thacker Pass lithium-project joint venture.